Pulmonary arterial hypertension: pathogenesis and clinical management

T Thenappan, ML Ormiston, JJ Ryan, SL Archer - Bmj, 2018 - bmj.com
Pulmonary hypertension is defined as a resting mean pulmonary artery pressure of 25 mm
Hg or above. This review deals with pulmonary arterial hypertension (PAH), a type of …

Interleukin (IL-6) immunotherapy

T Tanaka, M Narazaki… - Cold Spring Harbor …, 2018 - cshperspectives.cshlp.org
Interleukin 6 (IL-6) is a prototypical cytokine for maintaining homeostasis. When
homeostasis is disrupted by infections or tissue injuries, IL-6 is produced immediately and …

Perivascular inflammation in pulmonary arterial hypertension

Y Hu, L Chi, WM Kuebler, NM Goldenberg - Cells, 2020 - mdpi.com
Perivascular inflammation is a prominent pathologic feature in most animal models of
pulmonary hypertension (PH) as well as in pulmonary arterial hypertension (PAH) patients …

Drug delivery to macrophages: a review of targeting drugs and drug carriers to macrophages for inflammatory diseases

W He, N Kapate, CW Shields IV, S Mitragotri - Advanced drug delivery …, 2020 - Elsevier
Macrophages play a key role in defending against foreign pathogens, healing wounds, and
regulating tissue homeostasis. Driving this versatility is their phenotypic plasticity, which …

Involvement of CXCR4 in normal and abnormal development

N Kawaguchi, TT Zhang, T Nakanishi - Cells, 2019 - mdpi.com
CXC motif chemokine receptor type 4 (CXCR4) is associated with normal and abnormal
development, including oncogenesis. The ligand of CXCR4 is stromal cell-derived factor …

Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension

Y Tamura, C Phan, L Tu, M Le Hiress… - The Journal of …, 2018 - Am Soc Clin Investig
Pulmonary arterial hypertension (PAH) is characterized by a progressive accumulation of
pulmonary artery smooth muscle cells (PA-SMCs) in pulmonary arterioles leading to the …

Immunity and inflammation in pulmonary arterial hypertension: from pathophysiology mechanisms to treatment perspective

R Wang, T Yuan, J Wang, Y Chen, J Zhao, M Li… - Pharmacological …, 2022 - Elsevier
Pulmonary arterial hypertension (PAH) is a severe cardiopulmonary dysfunctional disease,
characterized by progressive vascular remodeling. Inflammation is an increasingly …

Contribution of metabolic reprogramming to macrophage plasticity and function

KCEL Kasmi, KR Stenmark - Seminars in immunology, 2015 - Elsevier
Macrophages display a spectrum of functional activation phenotypes depending on the
composition of the microenvironment they reside in, including type of tissue/organ and …

Variegated overexpression of chromosome 21 genes reveals molecular and immune subtypes of Down syndrome

MG Donovan, NP Eduthan, KP Smith, EC Britton… - Nature …, 2024 - nature.com
Individuals with Down syndrome, the genetic condition caused by trisomy 21, exhibit strong
inter-individual variability in terms of developmental phenotypes and diagnosis of co …

Potassium channel subfamily K member 3 (KCNK3) contributes to the development of pulmonary arterial hypertension

F Antigny, A Hautefort, J Meloche, M Belacel-Ouari… - Circulation, 2016 - Am Heart Assoc
Background—Mutations in the KCNK3 gene have been identified in some patients suffering
from heritable pulmonary arterial hypertension (PAH). KCNK3 encodes an outward rectifier …